Strikingly, these results were confirmed in vivo not only in a mouse xenograft model where coordinated autophagy and mTOR inhibition induced tumor remission only in HIF-2α-silenced cells, but importantly, were also confirmed in patient-derived primary colon cancer cells. This evidence concerns the gene MTOR and malignant colon neoplasm.